E-LIB Suche - Ergebnisse für: Nicolau, David P.

1

Non-KPC Attributes of Newer β-lactam/β-lactamase Inhibitors..:

Fratoni, Andrew J ; Gethers, Matthew L ; Nicolau, David P.
Clinical Infectious Diseases. , 2024

Link: https://doi.org/10.1093/..

2

Deciphering the Efficacy of β-Lactams in the Face of Metall..:

Abdelraouf, Kamilia ; Gill, Christian M ; Gethers, Matthew...
Open Forum Infectious Diseases. 11 (2024) 5 - p. , 2024

Link: https://doi.org/10.1093/..

3

Imipenem/relebactam pharmacokinetics in critically ill pati..:

Fratoni, Andrew J ; Kois, Abigail K ; Gluck, Jason A..
Journal of Antimicrobial Chemotherapy. 79 (2024) 5 - p. 1118-1125 , 2024

Link: https://doi.org/10.1093/..

4

Assessing the in vivo impact of novel β-lactamase inhibitor..:

Ruiz, Victor H ; Gill, Christian M ; Nicolau, David P
Journal of Antimicrobial Chemotherapy. 79 (2024) 3 - p. 546-551 , 2024

Link: https://doi.org/10.1093/..

5

A New Dosing Frontier: Retrospective Assessment of Effluent..:

Lakshmipathy, Damini ; Ye, Xiaoyi ; Kuti, Joseph L...
Critical Care Explorations. 6 (2024) 4 - p. e1065 , 2024

Link: https://doi.org/10.1097/..

6

Assessing the impact of meropenem exposure on ceftolozane/t..:

Fouad, Aliaa ; Nicolau, Samantha E ; Tamma, Pranita D...
Journal of Antimicrobial Chemotherapy. 79 (2024) 5 - p. 1176-1181 , 2024

Link: https://doi.org/10.1093/..

7

2798. Difficult to treat GES and KPC harboring Pseudomonas ..:

Ruiz, Victor H ; Gill, Christian ; Nicolau, David P
Open Forum Infectious Diseases. 10 (2023) Supplement_2 - p. , 2023

Link: https://doi.org/10.1093/..

8

Bronchopulmonary disposition of IV cefepime/taniborbactam (..:

Asempa, Tomefa E ; Kuti, Joseph L ; Nascimento, Jeffrey C...
Journal of Antimicrobial Chemotherapy. 78 (2023) 3 - p. 703-709 , 2023

Link: https://doi.org/10.1093/..

9

In vivoefficacy & resistance prevention of cefiderocol in c..:

Gill, Christian M ; Santini, Debora ; Takemura, Miki...
Journal of Antimicrobial Chemotherapy. 78 (2023) 4 - p. 983-990 , 2023

Link: https://doi.org/10.1093/..

10

Activity of novel β-lactam/β-lactamase inhibitor combinatio..:

Lee, Su Young ; Gill, Christian M ; Nicolau, David P...
Journal of Antimicrobial Chemotherapy. 78 (2023) 12 - p. 2795-2800 , 2023

Link: https://doi.org/10.1093/..

11

Antimicrobial Activity of Tebipenem and Comparators against..:

Asempa, Tomefa E. ; Bobenchik, April M. ; Bourassa, Lori...
International Journal of Antimicrobial Agents. 61 (2023) 3 - p. 106733 , 2023

Link: https://doi.org/10.1016/..

12

Imipenem/funobactam (formerly XNW4107) in vivo pharmacodyna..:

Fratoni, Andrew J ; Berry, Angela V ; Liu, Xiao...
Journal of Antimicrobial Chemotherapy. 78 (2023) 9 - p. 2343-2353 , 2023

Link: https://doi.org/10.1093/..

13

Assessing the in vivo efficacy of rational antibiotics and ..:

Abouelhassan, Yasmeen ; Gill, Christian M ; Nicolau, David P
Journal of Antimicrobial Chemotherapy. 78 (2023) 8 - p. 1843-1847 , 2023

Link: https://doi.org/10.1093/..

14

Inhaled amikacin for pneumonia treatment and dissemination ..:

Motos, Ana ; Yang, Hua ; Li Bassi, Gianluigi...
Critical Care. 27 (2023) 1 - p. , 2023

Link: https://doi.org/10.1186/..

15

Cefiderocol is Not Sequestered in an Ex Vivo Extracorporeal..:

Berry, Angela V. ; Conelius, Allison ; Gluck, Jason A...
European Journal of Drug Metabolism and Pharmacokinetics. 48 (2023) 4 - p. 437-441 , 2023

Link: https://doi.org/10.1007/..